Identification of EP300 as a Key Gene Involved in Antipsychotic-Induced Metabolic Dysregulation Based on Integrative Bioinformatics Analysis of Multi-Tissue Gene Expression Data.

Saved in:
Bibliographic Details
Title: Identification of EP300 as a Key Gene Involved in Antipsychotic-Induced Metabolic Dysregulation Based on Integrative Bioinformatics Analysis of Multi-Tissue Gene Expression Data.
Authors: Martínez-Pinteño A; Department of Basic Clinical Practice, Pharmacology Unit, University of Barcelona, Barcelona, Spain., Gassó P; Department of Basic Clinical Practice, Pharmacology Unit, University of Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain., Prohens L; Department of Basic Clinical Practice, Pharmacology Unit, University of Barcelona, Barcelona, Spain., Segura AG; Department of Basic Clinical Practice, Pharmacology Unit, University of Barcelona, Barcelona, Spain., Parellada M; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain.; Department of Child and Adolescent Psychiatry, Hospital General Universitario Gregorio Marañón, School of Medicine, Universidad Complutense, IiSGM, Madrid, Spain., Saiz-Ruiz J; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain.; Department of Psychiatry, Hospital Universitario Ramón y Cajal, IRYCIS, Universidad de Alcalá, Madrid, Spain., Cuesta MJ; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain.; Department of Psychiatry, Complejo Hospitalario de Navarra, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain., Bernardo M; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain.; Barcelona Clínic Schizophrenia Unit, Hospital Clínic de Barcelona, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain., Lafuente A; Department of Basic Clinical Practice, Pharmacology Unit, University of Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain., Mas S; Department of Basic Clinical Practice, Pharmacology Unit, University of Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain., Rodríguez N; Department of Basic Clinical Practice, Pharmacology Unit, University of Barcelona, Barcelona, Spain.
Source: Frontiers in pharmacology [Front Pharmacol] 2021 Aug 13; Vol. 12, pp. 729474. Date of Electronic Publication: 2021 Aug 13 (Print Publication: 2021).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34483940
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Identification of EP300 as a Key Gene Involved in Antipsychotic-Induced Metabolic Dysregulation Based on Integrative Bioinformatics Analysis of Multi-Tissue Gene Expression Data.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Martínez-Pinteño+A%22">Martínez-Pinteño A</searchLink>; Department of Basic Clinical Practice, Pharmacology Unit, University of Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Gassó+P%22">Gassó P</searchLink>; Department of Basic Clinical Practice, Pharmacology Unit, University of Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Prohens+L%22">Prohens L</searchLink>; Department of Basic Clinical Practice, Pharmacology Unit, University of Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Segura+AG%22">Segura AG</searchLink>; Department of Basic Clinical Practice, Pharmacology Unit, University of Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Parellada+M%22">Parellada M</searchLink>; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain.; Department of Child and Adolescent Psychiatry, Hospital General Universitario Gregorio Marañón, School of Medicine, Universidad Complutense, IiSGM, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Saiz-Ruiz+J%22">Saiz-Ruiz J</searchLink>; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain.; Department of Psychiatry, Hospital Universitario Ramón y Cajal, IRYCIS, Universidad de Alcalá, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Cuesta+MJ%22">Cuesta MJ</searchLink>; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain.; Department of Psychiatry, Complejo Hospitalario de Navarra, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Bernardo+M%22">Bernardo M</searchLink>; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain.; Barcelona Clínic Schizophrenia Unit, Hospital Clínic de Barcelona, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Lafuente+A%22">Lafuente A</searchLink>; Department of Basic Clinical Practice, Pharmacology Unit, University of Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Mas+S%22">Mas S</searchLink>; Department of Basic Clinical Practice, Pharmacology Unit, University of Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Rodríguez+N%22">Rodríguez N</searchLink>; Department of Basic Clinical Practice, Pharmacology Unit, University of Barcelona, Barcelona, Spain.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101548923%22">Frontiers in pharmacology</searchLink> [Front Pharmacol] 2021 Aug 13; Vol. 12, pp. 729474. <i>Date of Electronic Publication: </i>2021 Aug 13 (<i>Print Publication: </i>2021).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media]%22">Frontiers Media] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101548923 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1663-9812 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216639812%22">16639812 </searchLink><i>NLM ISO Abbreviation: </i>Front Pharmacol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34483940
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fphar.2021.729474
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 729474
    Titles:
      – TitleFull: Identification of EP300 as a Key Gene Involved in Antipsychotic-Induced Metabolic Dysregulation Based on Integrative Bioinformatics Analysis of Multi-Tissue Gene Expression Data.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Martínez-Pinteño A
      – PersonEntity:
          Name:
            NameFull: Gassó P
      – PersonEntity:
          Name:
            NameFull: Prohens L
      – PersonEntity:
          Name:
            NameFull: Segura AG
      – PersonEntity:
          Name:
            NameFull: Parellada M
      – PersonEntity:
          Name:
            NameFull: Saiz-Ruiz J
      – PersonEntity:
          Name:
            NameFull: Cuesta MJ
      – PersonEntity:
          Name:
            NameFull: Bernardo M
      – PersonEntity:
          Name:
            NameFull: Lafuente A
      – PersonEntity:
          Name:
            NameFull: Mas S
      – PersonEntity:
          Name:
            NameFull: Rodríguez N
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 13
              M: 08
              Text: 2021 Aug 13
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-print
              Value: 1663-9812
          Numbering:
            – Type: volume
              Value: 12
          Titles:
            – TitleFull: Frontiers in pharmacology
              Type: main
ResultId 1